JP Morgan Chase
TRAW icon

JP Morgan Chase’s Traws Pharma TRAW Stock Holding History

JP Morgan Chase’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2
Closed -$25 – 7735
2024
Q2 		$25 Hold
2
– – ﹤0.01% 7147
2024
Q1 		$52 Buy
2
+1
+100% +$19 ﹤0.01% 7029
2023
Q4 		$27 Hold
1
– – ﹤0.01% 7295
2023
Q3 		$18 Buy
+1
New +$23 ﹤0.01% 7199
2022
Q2 		– Sell
-193
Closed -$9K – 6953
2022
Q1 		$9K Buy
+193
New +$8.95K ﹤0.01% 6237
2020
Q4 		– Sell
-166
Closed -$17K – 5982
2020
Q3 		$17K Buy
+166
New +$41K ﹤0.01% 5184
2018
Q4 		– Hold
0
– – – 5971
2018
Q3 		– Hold
0
– – – 5860
2013
Q4 		– Sell
-2
Closed -$3.25M – 4262
2013
Q3 		$3.25M Buy
+2
New +$2.86M ﹤0.01% 2480

Other funds holding TRAW

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
VWWMG
Vermillion & White Wealth Management Group Phoenixville, Pennsylvania $174M AUM 15.31% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

JP Morgan Chase's TRAW Position: Q3 2024 in Review

JP Morgan Chase sold out of Traws Pharma (TRAW) in Q3 2024, closing a stake of 2 shares — an estimated $25 sold.

JP Morgan Chase first reported a position in TRAW in Q3 2013 and held it in 7 quarters. The position peaked at $3.25M in Q3 2013. 12 funds tracked by Wall St. Rank hold TRAW as of Q3 2024.

  • JP Morgan Chase reported no remaining Traws Pharma position as of Q3 2024 after selling out during the quarter.
  • JP Morgan Chase sold 2 Traws Pharma shares in Q3 2024, an estimated $25.
  • JP Morgan Chase first reported a position in Traws Pharma in Q3 2013 and held it in 7 quarters.
  • JP Morgan Chase's Traws Pharma position peaked at $3.25M in Q3 2013.
  • 12 funds tracked by Wall St. Rank held Traws Pharma as of Q3 2024.

Based on JP Morgan Chase's 13F filing for Q3 2024, filed 8 Nov 2024.